000928600 000__ 05595cam\a2200421Ia\4500
000928600 001__ 928600
000928600 005__ 20230306151305.0
000928600 006__ m\\\\\o\\d\\\\\\\\
000928600 007__ cr\un\nnnunnun
000928600 008__ 200215s2020\\\\si\\\\\\o\\\\\000\0\eng\d
000928600 020__ $$a9789813297050$$q(electronic book)
000928600 020__ $$a9813297050$$q(electronic book)
000928600 020__ $$z9789813297043
000928600 035__ $$aSP(OCoLC)on1139910577
000928600 035__ $$aSP(OCoLC)1139910577
000928600 040__ $$aEBLCP$$beng$$cEBLCP$$dGW5XE$$dESU$$dOCLCF
000928600 049__ $$aISEA
000928600 050_4 $$aRC531
000928600 08204 $$a616.85/22$$223
000928600 24500 $$aAnxiety disorders :$$brethinking and understanding recent discoveries /$$cYong-Ku Kim, editor.
000928600 260__ $$aSingapore :$$bSpringer,$$c2020.
000928600 300__ $$a1 online resource (566 pages).
000928600 336__ $$atext$$btxt$$2rdacontent
000928600 337__ $$acomputer$$bc$$2rdamedia
000928600 338__ $$aonline resource$$bcr$$2rdacarrier
000928600 4901_ $$aAdvances in Experimental Medicine and Biology ;$$vv.1191
000928600 5050_ $$aPart 1. Brain network concepts -- Chapter 1. Task MRI-based functional brain network of anxiety -- Chapter 2. Phenotype network and brain structural covariance network of anxiety -- Chapter 3. linear/nonlinear micro-and-macro state EEG-based functional networks for anxiety -- Chapter 4. White matter-based structural brain network of anxiety -- Chapter 5. Resting state abnormalities in anxiety disorders and spatiotemporal psychopathology -- Part 2. Neurobiological Aspects -- Chapter 6. Gene-environmental interactions and role of epigenetics in anxiety disorders -- Chapter 7. The role of the oxytocin system in anxiety disorders -- Chapter 8. Translational studies in the complex roles of neurotransmitter systems in anxiety and anxiety disorders -- Chapter 9. The role of early life stress in HPA axis dysfunction in anxiety disorders -- Chapter 10. Immune-kynurenine pathways and the gut-microbiota-brain axis in anxiety disorders -- Chapter 11. Experimental anxiety model for anxiety disorders: relevance to drug discovery -- Part 3. Diagnostic and clinical Issues -- Chapter 12. Anxiety disorders in DSM-5: changes, controversies, and future directions -- Chapter 13. Biological markers to differentiate the type of anxiety disorders -- Chapter 14. Comorbid anxiety and depression: clinical and conceptual consideration, transdiagnostic treatment -- Chapter 15. Anxiety disorders and medical comorbidity: treatment implications -- Part 4. Therapeutic Issues -- Chapter 16. Biofeedback and Neurofeedback for Anxiety Disorders: A Quantitative and Qualitative Systematic Review -- Chapter 17. Cognitive Behavioral Therapy, Mindfulness-Based Cognitive Therapy and Acceptance Commitment Therapy for Anxiety Disorders: Integrating Traditional with Digital Treatment Approaches -- Chapter 18. Neurostimulation in anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder -- Chapter 19. Current and novel psychopharmacological drugs for anxiety disorders -- Chapter 20. Role of benzodiazepines in anxiety disorders -- Chapter 21. Virtual Reality for Anxiety Disorders: Rethinking a Field in Expansion -- Chapter 22. Current research on complementary and alternative medicine (CAM) in the treatments of anxiety disorders: evidence based review -- Chapter 23. Contemporary Psychodynamic Approaches to Treating Anxiety: Theory, Research, and Practice -- Chapter 24. Well-being therapy in anxiety disorders -- Part 5. Anxiety and precision psychiatry -- Chapter 25. Personalized clinical approaches to anxiety disorders -- Chapter 26. The role of hormonal and reproductive status in the treatment of anxiety disorders in women -- Chapter 27. Risk factors and prevention strategies for anxiety disorders in childhood and adolescence -- Chapter 28. Anxiety disorders in the elderly.
000928600 506__ $$aAccess limited to authorized users.
000928600 520__ $$aThis book reviews all important aspects of anxiety disorders with the aim of shedding new light on these disorders through combined understanding of traditional and novel paradigms. The book is divided into five sections, the first of which reinterprets anxiety from a network science perspective, examining the altered topological properties of brain networks in anxiety disorders. The second section discusses recent advances in understanding of the neurobiology of anxiety disorders, covering, for example, gene-environmental interactions and the roles of neurotransmitter systems and the oxytocin system. A wide range of diagnostic and clinical issues in anxiety disorders are then addressed, before turning attention to contemporary treatment approaches in the context of novel bio-psychosocial-behavioral models, including bio- and neurofeedback, cognitive behavioral therapy, neurostimulation, virtual reality exposure therapy, pharmacological interventions, psychodynamic therapy, and CAM options. The final section is devoted to precision psychiatry in anxiety disorders, an increasingly important area as we move toward personalized treatment. Anxiety Disorders will be of interest for all researchers and clinicians in the field.
000928600 588__ $$aDescription based on print version record.
000928600 650_0 $$aAnxiety disorders.
000928600 7001_ $$aKim, Yong-Ku.
000928600 77608 $$iPrint version:$$aKim, Yong-Ku$$tAnxiety Disorders : Rethinking and Understanding Recent Discoveries$$dSingapore : Springer,c2020$$z9789813297043
000928600 830_0 $$aAdvances in experimental medicine and biology ;$$vv. 1191.
000928600 852__ $$bebk
000928600 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-981-32-9705-0$$zOnline Access$$91397441.1
000928600 909CO $$ooai:library.usi.edu:928600$$pGLOBAL_SET
000928600 980__ $$aEBOOK
000928600 980__ $$aBIB
000928600 982__ $$aEbook
000928600 983__ $$aOnline
000928600 994__ $$a92$$bISE